Dr. Jonathan D. Greifenkamp, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,459
Licensed in Texas since 2003, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: University of Texas Medical Branch at Galveston
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
TX license L6919 (first issued 2003; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christus Good Shepherd Medical Center Longview, TX
- Longview Regional Medical Center Longview, TX
Medical groups
- Regional Clinics of Longview (40 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,459
- Services billed
- 8,798
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, regadenoson, 0.1 mg | 852 | 213 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 470 | 446 |
| Established patient office or other outpatient visit, 30-39 minutes | 417 | 352 |
| Established patient office or other outpatient visit, 20-29 minutes | 373 | 347 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 269 | 252 |
| Heart muscle strain imaging | 245 | 236 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 242 | 233 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 239 | 238 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 237 | 237 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 179 | 61 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Longview, TX | 692 |
| Atorvastatin Calcium Other prescribers in Longview, TX | 373 |
| Eliquis (apixaban) Other prescribers in Longview, TX | 342 |
| Carvedilol Other prescribers in Longview, TX | 291 |
| Furosemide Other prescribers in Longview, TX | 237 |
| Ezetimibe Other prescribers in Longview, TX | 237 |
| Rosuvastatin Calcium Other prescribers in Longview, TX | 216 |
| Metoprolol Tartrate Other prescribers in Longview, TX | 197 |
| Metoprolol Succinate Other prescribers in Longview, TX | 183 |
| Potassium Chloride Other prescribers in Longview, TX | 179 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 174 payments worth $3,417 in total to this clinician.
| Edwards Lifesciences Corporation | $480 |
|---|---|
| Abbott Laboratories | $421 |
| Boston Scientific Corporation | $316 |
| Biosense Webster, Inc. | $310 |
| Merck Sharp & Dohme LLC | $227 |
| Cvrx, Inc. | $216 |
| W. L. Gore & Associates, Inc. | $213 |
| Stryker Corporation | $200 |
| Food and Beverage | $3,417 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.